• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射曲安奈德后出现玻璃体混浊——病例报告

Vitreous opacities after intravitreal triamcinolone injection- a case report.

作者信息

Ratra Dhanashree, Ratra Vineet, Shah Haard

机构信息

Department of Vitreoretinal Diseases, Medical Research Foundation, Sankara Nethralaya, 41, College Road, Chennai, 600006, India.

Department of Comprehensive Ophthalmology, Medical Research Foundation, Sankara Nethralaya, 41, College Road, Chennai, 600006, India.

出版信息

BMC Ophthalmol. 2018 Jun 20;18(1):145. doi: 10.1186/s12886-018-0818-y.

DOI:10.1186/s12886-018-0818-y
PMID:29925346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6011592/
Abstract

BACKGROUND

We report occurrence of peculiar tiny white thread like vitreous opacities after intravitreal triamcinolone injection. These persisted without any change for over a year. We ascribe them to aggregation of triamcinolone crystals due to the purification methods.

CASE PRESENTATION

Seven patients (8 eyes) with macular edema developed tiny whitish thread like opacities in the vitreous 2-3 months after undergoing an intravitreal injection of triamcinolone acetonide preparation containing benzyl alcohol as preservative. These opacities persisted unchanged for more than a year. The follow up ranged from 91 to 425 days. Vitreous tap was done in one patient which was negative for infection. All patients initially showed improvement but needed re-treatment for recurrence. One patient developed steroid induced rise in intraocular pressure. Microscopic examination of the drug revealed large string like aggregates of triamcinolone crystals.

CONCLUSIONS

We hypothesize the possibility of aggregation of triamcinolone crystals into string like structures probably due to the purification methods used during manufacture which led to these thread like opacities in the vitreous.

摘要

背景

我们报告了玻璃体内注射曲安奈德后出现特殊的微小白色线状玻璃体混浊。这些混浊持续一年多未发生任何变化。我们将其归因于纯化方法导致的曲安奈德晶体聚集。

病例报告

7例(8只眼)黄斑水肿患者在玻璃体内注射含有苯甲醇作为防腐剂的曲安奈德丙酮制剂后2 - 3个月,玻璃体中出现微小的白色线状混浊。这些混浊持续一年多未变。随访时间为91至425天。对1例患者进行了玻璃体穿刺,结果显示无感染。所有患者最初均有改善,但复发后需要再次治疗。1例患者出现类固醇诱导的眼压升高。对药物进行显微镜检查发现曲安奈德晶体形成大的串状聚集体。

结论

我们推测曲安奈德晶体可能聚集成串状结构,这可能是由于生产过程中使用的纯化方法导致玻璃体中出现这些线状混浊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/f88ca3682328/12886_2018_818_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/1778e697b10d/12886_2018_818_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/e7daa78d7f37/12886_2018_818_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/f88ca3682328/12886_2018_818_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/1778e697b10d/12886_2018_818_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/e7daa78d7f37/12886_2018_818_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a79f/6011592/f88ca3682328/12886_2018_818_Fig3_HTML.jpg

相似文献

1
Vitreous opacities after intravitreal triamcinolone injection- a case report.玻璃体内注射曲安奈德后出现玻璃体混浊——病例报告
BMC Ophthalmol. 2018 Jun 20;18(1):145. doi: 10.1186/s12886-018-0818-y.
2
Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.玻璃体内注射曲安奈德治疗糖尿病性黄斑水肿的两年结果
Int Ophthalmol. 2007 Oct;27(5):299-306. doi: 10.1007/s10792-007-9072-7. Epub 2007 Apr 24.
3
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.玻璃体内注射与后Tenon囊下注射曲安奈德治疗弥漫性糖尿病性黄斑水肿的比较。
Ophthalmology. 2005 Sep;112(9):1557-63. doi: 10.1016/j.ophtha.2005.03.023.
4
Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜静脉阻塞所致黄斑水肿。
Eye (Lond). 2008 Jan;22(1):60-4. doi: 10.1038/sj.eye.6702518. Epub 2006 Aug 11.
5
Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.曲安奈德玻璃体内重复高剂量注射治疗弥漫性糖尿病性黄斑水肿
Ophthalmology. 2006 May;113(5):800-4. doi: 10.1016/j.ophtha.2006.01.002. Epub 2006 Mar 13.
6
Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.在难治性葡萄膜炎性黄斑水肿中反复玻璃体内注射曲安奈德后视觉功能丧失
Int Ophthalmol. 2009 Oct;29(5):427-9. doi: 10.1007/s10792-008-9248-9. Epub 2008 Jul 10.
7
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜中央静脉阻塞相关的黄斑水肿。
Arch Ophthalmol. 2004 Aug;122(8):1131-6. doi: 10.1001/archopht.122.8.1131.
8
Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.玻璃体内注射与球后注射曲安奈德治疗视网膜分支静脉阻塞相关黄斑水肿的比较
Am J Ophthalmol. 2005 Jun;139(6):972-82. doi: 10.1016/j.ajo.2004.12.087.
9
Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.玻璃体内注射贝伐单抗与玻璃体内和后Tenon 曲安奈德治疗葡萄膜炎性囊样黄斑水肿的疗效和安全性比较。
Retina. 2011 Jan;31(1):111-8. doi: 10.1097/IAE.0b013e3181e378af.
10
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.前瞻性研究曲安奈德与贝伐单抗治疗视网膜中央静脉阻塞继发黄斑水肿。
Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

本文引用的文献

1
Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.玻璃体内注射曲安奈德与玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿的荟萃分析
Int J Ophthalmol. 2013 Aug 18;6(4):546-52. doi: 10.3980/j.issn.2222-3959.2013.04.26. eCollection 2013.
2
Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibility.无防腐剂曲安奈德丙酮混悬液与“传统”曲安奈德制剂的比较:颗粒大小对视网膜生物相容性的影响。
Retina. 2011 Nov;31(10):2050-7. doi: 10.1097/IAE.0b013e318214d076.
3
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
瑞尼珠单抗联合即刻或延迟激光或曲安奈德联合即刻激光治疗糖尿病黄斑水肿的 2 年扩展随访。
Ophthalmology. 2011 Apr;118(4):609-14. doi: 10.1016/j.ophtha.2010.12.033.
4
Triamcinolone crystal size.曲安奈德晶体大小。
Ophthalmology. 2010 Aug;117(8):1654, 1654.e1-4. doi: 10.1016/j.ophtha.2010.01.052.
5
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.一项比较玻璃体内注射曲安奈德与标准治疗方案治疗视网膜分支静脉阻塞继发黄斑水肿所致视力丧失的疗效和安全性的随机试验:视网膜静脉阻塞的标准治疗与皮质类固醇治疗(SCORE)研究报告6
Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233.
6
Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior.曲安奈德制剂:晶体大小对体外行为的影响。
Retina. 2009 May;29(5):689-98. doi: 10.1097/IAE.0b013e31819e390a.
7
Ultrasonographic pictures of intravitreal triamcinolone acetonide.
Eur J Ophthalmol. 2009 Mar-Apr;19(2):263-7. doi: 10.1177/112067210901900214.
8
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.一项比较玻璃体内注射曲安奈德与局部/格栅光凝治疗糖尿病性黄斑水肿的随机试验。
Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. doi: 10.1016/j.ophtha.2008.06.015. Epub 2008 Jul 26.
9
Influence of different purification techniques on triamcinolone yield and particle size spectrum.不同纯化技术对曲安奈德产率和粒度分布的影响。
Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):689-96. doi: 10.1007/s00417-006-0436-x. Epub 2006 Sep 28.
10
Persistent depot of triamcinolone acetonide after a single intravitreal injection.
Indian J Ophthalmol. 2005 Mar;53(1):65-6. doi: 10.4103/0301-4738.15291.